
Sign up to save your podcasts
Or


In part 2 Prof. Nicolas Mottet discusses which are the most important changes in the new EAU Guidelines for Prostate Cancer treatment related to genetic testing, M1 disease and Castration-resistant prostate cancer (CRPC).
Listen also to part 1 about perineal biopsy, staging PSMA, adjuvant Radio Therapy.
By European Association of Urology3.7
33 ratings
In part 2 Prof. Nicolas Mottet discusses which are the most important changes in the new EAU Guidelines for Prostate Cancer treatment related to genetic testing, M1 disease and Castration-resistant prostate cancer (CRPC).
Listen also to part 1 about perineal biopsy, staging PSMA, adjuvant Radio Therapy.

322 Listeners

504 Listeners

58 Listeners

39 Listeners

97 Listeners

83 Listeners

280 Listeners

37 Listeners

58 Listeners

2 Listeners

88 Listeners

55 Listeners

13 Listeners

0 Listeners

14 Listeners